The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $14.25

Today's change-0.36 -2.43%
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $14.25

Today's change-0.36 -2.43%
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc down (U.S.)$0.36

Allscripts Healthcare Solutions Inc closed sharply lower Tuesday, dropping (U.S.)$0.36 or 2.43% to (U.S.)$14.25. Over the last five days, shares have gained 0.42% and 11.55% year to date. Shares have underperformed the S&P 500 by 14.60% during the last year.

Key company metrics

  • Open(U.S.) $14.55
  • Previous close(U.S.) $14.60
  • High(U.S.) $14.58
  • Low(U.S.) $14.20
  • Bid / Ask-- / --
  • YTD % change+11.55%
  • Volume2,900,062
  • Average volume (10-day)2,721,020
  • Average volume (1-month)3,568,196
  • Average volume (3-month)3,186,840
  • 52-week range(U.S.) $11.00 to (U.S.) $17.17
  • Beta1.03
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward33.66×
  • Forward PEG1.25×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.31
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-4.07%

Although this company's net profit margin is negative, it is above the industry average and implies that Allscripts Healthcare Solutions Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.90%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue335341345351
Total other revenue--------
Total revenue335341345351
Gross profit130136131140
Total cost of revenue205205214211
Total operating expense340340364360
Selling / general / administrative82859787
Research & development47424653
Depreciation / amortization7978
Interest expense (income), net operating--------
Unusual expense (income)0002
Other operating expenses, total--------
Operating income-61-19-9
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-11-7-26-16
Income after tax-10-2-26-18
Income tax, total-1-402
Net income-10-2-26-18
Total adjustments to net income--------
Net income before extra. items-10-2-26-18
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-2-26-18
Inc. avail. to common incl. extra. items-10-2-26-18
Diluted net income-10-2-26-18
Dilution adjustment------0
Diluted weighted average shares181180180180
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.01-0.14-0.10
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.06-0.01-0.14-0.09